Literature DB >> 10937612

Lack of sertraline efficacy probably due to an interaction with carbamazepine.

A Khan, M U Shad, S H Preskorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10937612     DOI： 10.4088/jcp.v61n0712a

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  4 in total

1.  Significant reduction of sertraline plasma levels by carbamazepine and phenytoin.

Authors:  Maria Pihlsgård; Erik Eliasson
Journal:  Eur J Clin Pharmacol       Date:  2002-02       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of sertraline.

Authors:  C Lindsay DeVane; Heidi L Liston; John S Markowitz
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.

Authors:  Chaitali Ghosh; Mohammad Hossain; Addison Spriggs; Arnab Ghosh; Gerald A Grant; Nicola Marchi; Emilio Perucca; Damir Janigro
Journal:  Epilepsia       Date:  2015-02-05       Impact factor: 5.864

4.  PharmGKB summary: sertraline pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Kevin Hicks; Laura B Ramsey; Jeffrey R Strawn; D Max Smith; Margarita Bobonis Babilonia; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.